Dear All, Based on a 2020 RFP, we’ve known that WHO was building a fungal priority pathogen list (PPL). Well, now the list has been released. Here’s what you need to understand the new PPL: Webpage where you can get the report My PowerPoint .pptx that summarizes all the PPLs to date My webpage that provides
Dear All: The new WHO priority pathogen list for R&D has been released! It’s entirely focused on bacteria both otherwise has a lot of similarity the CDC list. FYI, CARB-X will use both lists going forward. Links to WHO materials are below. I have also prepared a short slide deck (updated on 22 Dec 2017) that shows
Dear All, In addition to forming the inaugural WHO Task Force of AMR Survivors, the WHO has also recently released a report entitled “Awareness-raising on Antimicrobial Resistance: Report of global consultation meetings.” The report is based on discussions at two meetings held by WHO with stakeholders from across the world. Even before opening the report,
Dear All, The WHO has announced a call for expressions of interests from AMR survivors and their caregivers to serve in the inaugural WHO Task Force of AMR Survivors! WHO are specifically looking for both (i) survivors of a drug-resistant infection and (ii) anyone who was a direct caregiver of such a patient. Their goal is
Dear All, WHO continues on their streak of seeking support for their AMR-related work! Today we have a posting by the Tripartite Joint Secretariat on Antimicrobial Resistance (AMR) of a consultancy opening for an 11-month project that would support development of multisectoral guidance(s) on development and strengthening of the coordination mechanisms and governance structures for addressing AMR. Full details
Dear All, Three global conversations to put on your listen-to-this list! One is this coming week, one is during ECCMID, and one is a video you can listen to now! First up and happening in just a few days on Thursday 29 Apr (10a-6p EST), please mark your calendar for a UN General Assembly High-Level interactive
Dear All (this newsletter experiments with an Executive Summary/Details format; let me know what you think), (Executive Summary) As a further support for implementation of recommendations from the UN Interagency Coordination Group on Antimicrobial Resistance (IACG AMR), the Tripartite Plus (WHO-FAO-OIE-UNEP) are seeking to create a Partnership Platform that will “engage institutions representing states, markets and
Dear All, The WHO is looking for a consultant to develop a campaign to prevent non-prescription antibiotic sales! This 4-month contract sounds intriguing to say the least. This position is tied into (and culminates with) the annual World AMR Awareness Week — it’s interesting to see how the WHO is working to prevent this problem! Lots of
Dear All, I learned today from our colleagues at WHO that Alphafold has recently added the proteome of nearly all the WHO priority pathogens to their library of highly accurate prediction of protein structures. Alphafold was new to me and is amazing! Per our colleagues at WHO: AlphaFold is an AI system developed by DeepMind that
Dear All, First up, we have an update to WHO’s review of the clinical antibacterial pipeline. The review by Butler et al. in AAC (and for transparency, know that I am a co-author) covers both traditional and non-traditional products. It found that as of 30 June 2021: There were 76 antibacterial agents in clinical development